Doctors and Patients Differ on Perception of RA Disease Activity
Trial Looks at Treatment of Early Aggressive Rheumatoid Arthritis
Furin Has Protective Role in Immune Response-Induced Arthritis
Oxidative Stress Contributes to ERK Inactivation in Lupus T Cells
Targeting Upstream Kinases May Avoid p39 Blockade
ACR announcements
Patient's global assessment of disease activity: What are we measuring?
Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
Development and validation of a risk score for serious infection in patients with rheumatoid arthritis
Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis
Natural killer T cell deficiency in active adult-onset Still's Disease: Correlation of deficiency of natural killer t cells with dysfunction of natural killer cells
Protective role of systemic furin in immune response–induced arthritis
Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: Advantages of targeting upstream kinases MKK-3 or MKKk-6
Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation
Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement
Effects of equine joint injury on boundary lubrication of articular cartilage by synovial fluid: Role of hyaluronan
Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes
N -acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus
Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus
Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension
JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
The relationships between adult juvenile idiopathic arthritis and employment
Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation
Clinical Images: Ultrasonographic appearance of thyroid acropachy
Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: A systematic review and meta-analysis
Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus
On acute gouty arthritis: A paper entitled “Inflammatory Gout: Observations Over a Half-Century” * is represented here in limericks.
Role of β-catenin signaling in intervertebral disc degeneration: Comment on the article by Wang et al
Role of β-catenin signaling in intervertebral disc degeneration: Comment on the article by Wang et al
Serious adverse events—Missing in action: Comment on the article by Kremer et al
Serious adverse events—Missing in action: Comment on the article by Kremer et al
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody–associated vasculitis? Comment on the article by Walsh et al
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody–associated vasculitis? Comment on the article by Walsh et al
Anti-p155 autoantibodies as a diagnostic marker for cancer-associated dermatomyositis: Comment on the article by Trallero-Araguás et al
Anti-p155 autoantibodies as a diagnostic marker for cancer-associated dermatomyositis: Comment on the article by Trallero-Araguás et al